Covid-19 Drug 2-dg
- All
- News
- Videos
-
BDR Pharma Gets DRDO Nod To Manufacture, Sell Covid Drug 2-DG In India
BDR Pharma on Monday said it has inked a licensing pact with the Defence Research and Development Organisation (DRDO) to manufacture, distribute, and market COVID-19 drug 2-Deoxy-D-Glucose (2-DG) in the country.
-
DRDO Invites Applications From Indian Pharma Firms For Bulk Production Of Covid Drug 2-DG
The Defence Research and Development Organisation or DRDO, which developed 2-Deoxy-D-Glucose (2-DG), a drug used for treatment of COVID-19 patients, has called for Expression of Interest to transfer the technology to Indian pharmaceutical firms.
-
Rs 990 Per Sachet For Defence Research Body's Covid Drug '2-DG': Report
The price of a drug for COVID-19 patients developed by India's top defence research body has been fixed at Rs 990 per sachet, news agency ANI reported today quoting unnamed officials.
-
10,000 Sachets Of DRDO's Covid Drug To Hit Market Today, Says Rajnath Singh
Union Defence Minister Rajnath Singh informed that 10,000 sachets of anti-COVID drug 2-DG will be available in the market from Thursday. The anti-COVID drug has been developed by the Defence Research and Development Organisation (DRDO).
-
Data Suggests Phase-3 Trials For Covid Drug 2-DG May Continue Till August
With the government presenting DRDO-developed drug 2-DG as a potential game-changer in the fight against COVID-19, the clinical trial registry data suggests that the phase-3 trials for the medicine at over two dozen government and private hospitals
-
Will Examine 2-DG Drug Data To Add It To Covid Treatment Protocol: Centre
The government will consider including India's first indigenous anti-COVID drug 2-DG in the national COVID-19 treatment protocol after examining the data of the medicine, officials said Tuesday.
-
New Anti-Covid Drug "Should Work Against Various Strains": DRDO Chief
The Defence Research and Development Organisation's (DRDO) new anti-COVID drug 2-DG should work against various strains of the COVID-19 virus, DRDO chairperson Dr G Satheesh Reddy said today.
-
10,000 Packets Of DRDO's Anti-Covid Oral Drug To Be Distributed Today
An anti-coronavirus drug developed by Defence Research and Development Organisation (DRDO) will be launched tomorrow, with Union Defence Minister Rajnath Singh distributing nearly 10,000 doses to some hospitals in the national capital.
-
BDR Pharma Gets DRDO Nod To Manufacture, Sell Covid Drug 2-DG In India
BDR Pharma on Monday said it has inked a licensing pact with the Defence Research and Development Organisation (DRDO) to manufacture, distribute, and market COVID-19 drug 2-Deoxy-D-Glucose (2-DG) in the country.
-
DRDO Invites Applications From Indian Pharma Firms For Bulk Production Of Covid Drug 2-DG
The Defence Research and Development Organisation or DRDO, which developed 2-Deoxy-D-Glucose (2-DG), a drug used for treatment of COVID-19 patients, has called for Expression of Interest to transfer the technology to Indian pharmaceutical firms.
-
Rs 990 Per Sachet For Defence Research Body's Covid Drug '2-DG': Report
The price of a drug for COVID-19 patients developed by India's top defence research body has been fixed at Rs 990 per sachet, news agency ANI reported today quoting unnamed officials.
-
10,000 Sachets Of DRDO's Covid Drug To Hit Market Today, Says Rajnath Singh
Union Defence Minister Rajnath Singh informed that 10,000 sachets of anti-COVID drug 2-DG will be available in the market from Thursday. The anti-COVID drug has been developed by the Defence Research and Development Organisation (DRDO).
-
Data Suggests Phase-3 Trials For Covid Drug 2-DG May Continue Till August
With the government presenting DRDO-developed drug 2-DG as a potential game-changer in the fight against COVID-19, the clinical trial registry data suggests that the phase-3 trials for the medicine at over two dozen government and private hospitals
-
Will Examine 2-DG Drug Data To Add It To Covid Treatment Protocol: Centre
The government will consider including India's first indigenous anti-COVID drug 2-DG in the national COVID-19 treatment protocol after examining the data of the medicine, officials said Tuesday.
-
New Anti-Covid Drug "Should Work Against Various Strains": DRDO Chief
The Defence Research and Development Organisation's (DRDO) new anti-COVID drug 2-DG should work against various strains of the COVID-19 virus, DRDO chairperson Dr G Satheesh Reddy said today.
-
10,000 Packets Of DRDO's Anti-Covid Oral Drug To Be Distributed Today
An anti-coronavirus drug developed by Defence Research and Development Organisation (DRDO) will be launched tomorrow, with Union Defence Minister Rajnath Singh distributing nearly 10,000 doses to some hospitals in the national capital.
